1.
Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer. AO [Internet]. 2010 Oct. 1 [cited 2026 May 11];49(7):888-94. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32674